Advances in crystal nucleation for amorphous drugs
10.16438/j.0513-4870.2023-1447
- VernacularTitle:无定形态药物结晶成核研究进展
- Author:
Jie ZHANG
;
Kang LI
;
Zi-qing YANG
;
Zi-han DING
;
Sai-jun XIAO
;
Zhi-ming YUE
;
Li-mei CAI
;
Jia-wen LI
;
Ding KUANG
;
Min-zhuo LIU
;
Zhi-hong ZENG
- Publication Type:Research Article
- Keywords:
amorphous drug;
crystallization;
nucleation;
poorly water-soluble drug
- From:
Acta Pharmaceutica Sinica
2024;59(7):1962-1969
- CountryChina
- Language:Chinese
-
Abstract:
Amorphous solid dispersion (ASD) is one of the most effective formulation approaches to enhance the water solubility and oral bioavailability of poorly water-soluble drugs. However, maintenance of physical stability of amorphous drug is one of the main challenges in the development of ASD. Crystallization is a process of nucleation and crystal growth. The nucleation is the key factor that influences the physical stability of the ASD. However, a theoretical framework to describe the way to inhibit the nucleation of amorphous drug is not yet available. We reviewed the methods and theories of nucleation for amorphous drug. Meanwhile, we also summarized the research progress on the mechanism of additives influence on nucleation and environmental factors on nucleation. This review aims to enhance the better understanding mechanism of nucleation of amorphous drug and controlling over the crystal nucleation during the ASD formulation development.